Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis.
第一作者:
Howard N,Hodis
第一单位:
From the 1Atherosclerosis Research Unit, Keck School of Medicine, University of Southern California, Los Angeles, CA; 2Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA; 3Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA; 4Department of Molecular Pharmacology and Toxicology, School of Pharmacy, University of Southern California, Los Angeles, CA; 5Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA; 6Los Angeles Biomedical Research Institute at Harbor-University of California at Los Angeles Medical Center, Torrance, CA; and 7Departments of Health Research and Policy (Epidemiology) and Neurology and Neurological Sciences, Stanford University, Stanford, CA.
作者:
主题词
投药, 口服(Administration, Oral);动脉粥样硬化(Atherosclerosis);血压(Blood Pressure);人体质量指数(Body Mass Index);颈动脉(Carotid Arteries);冠状动脉疾病(Coronary Artery Disease);双盲法(Double-Blind Method);雌二醇(Estradiol);雌激素替代疗法(Estrogen Replacement Therapy);雌激素类(Estrogens);女(雌)性(Female);人类(Humans);脂类(Lipids);绝经期(Menopause);危险因素(Risk Factors);时间因素(Time Factors);体层摄影术, X线计算机(Tomography, X-Ray Computed)
DOI
10.1097/GME.0000000000000343
PMID
25380275
发布时间
2022-03-31
- 浏览18

Menopause (New York, N.Y.)
391-401页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文